AstraZeneca's total assets for Q1 2025 were $106.25B, an increase of 2.13% from the previous quarter. AZN total liabilities were $65.12B for the fiscal quarter, a 3.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.